Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Key to changes
?
Text removedfrom 2024 Q1- Text added to 2024 Q2
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. junior Avg
|
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. junior Avg
|
New words:
advertising, advisory, agency, aggressive, AI, Albert, alongside, Antonio, artificial, astrocytoma, attracting, began, Center, CFO, cisgender, complicated, contact, country, declined, disaggregated, disagree, disruption, dollar, effort, Einstein, ensure, evidence, expedited, export, favor, feasibility, feature, foregoing, forward, found, GBM, glioblastoma, guarantee, import, important, incomplete, infected, intelligence, intent, Jacob, KOL, Lalezari, landscape, larger, Leadership, manner, member, men, MGO, Migliarese, monotherapy, Montefiore, moving, multiforme, newly, nonqualified, opportunistic, outlining, pathway, pharmacokinetic, preclude, prescription, prohibited, properly, publish, publishing, quality, reelection, requisite, satisfactory, selection, short, side, Simplification, stand, statistical, strategic, successor, team, temozolomide, temporary, transgender, turnover, uncertainty, undesirable, unintended, unsecured, vascular, women
Valuein 2024 Q1 filing- Value in 2024 Q2 filing
Original filings
Filing view